Funds and ETFs Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-05-15 EDT 5-day change 1st Jan Change
237.3 USD +0.97% Intraday chart for Becton, Dickinson and Company +1.59% -2.68%

ETFs positioned on Becton, Dickinson and Company

Name Weight AuM 1st Jan change Investor Rating
0.25% 37 M€ -.--%
0.24% 36 M€ +3.82% -
0.24% 1,174 M€ +23.54%
0.24% 655 M€ -.--% -
0.24% 273 M€ -.--%
0.23% 6 M€ +17.98% -
0.23% 121 M€ +8.33% -
0.21% 26 M€ +16.85% -
0.21% 29 M€ -.--% -
0.21% 322 M€ +13.88% -
0.21% 1,487 M€ +8.31% -
0.20% 1 M€ -.--%
0.20% 206 M€ -.--%
0.20% 284 M€ -.--%
0.19% 34 M€ +12.38% -
0.19% 786 M€ -.--%
0.19% 23 M€ -.--% -
0.19% 57 M€ +21.00% -
0.18% 2,517 M€ +12.80% -
0.18% 375 M€ +9.38%
0.17% 9 M€ +11.16% -
0.16% 205 M€ -.--%
0.16% 14 M€ +16.19% -
0.15% 20 M€ +1.40% -
0.15% 283 M€ +19.85%
0.14% 1,166 M€ +0.26% -
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
237.3 USD
Average target price
278.8 USD
Spread / Average Target
+17.50%
Consensus
  1. Stock Market
  2. Equities
  3. BDX Stock
  4. Funds and ETFs Becton, Dickinson and Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW